Lonza has opened a new media development laboratory in Singapore to expand its bioprocessing capabilities in the Asia-Pacific region. The facility will focus on developing and optimizing cell culture media for biopharmaceutical manufacturing.
The Singapore lab will utilize Lonza's design of experiments (DOE) service, which evaluates multiple variables simultaneously to identify key performance drivers in media development. This approach aims to accelerate development timelines while reducing the number of experimental iterations required.